Compounded tirzepatide
GobyMeds vs NextMeds
Quick answer
NextMeds costs $109 a real month and GobyMeds costs $145 — a difference of $36 a month, or $427 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
What each one bills
| GobyMeds | NextMeds | |
|---|---|---|
| True monthly cost | $145 | $109 |
| Advertised as | $133 | $109 |
| Charged | every 12 weeks | every calendar month |
| Each charge | $399 | $109 |
| Price basis | a starting-dose price that climbs | the same at every dose |
| Mandatory recurring fee | none found | none found |
| States it names | not published | 50 states |
| FDA warning letter | none on record | none on record |
Where they actually differ
- They bill on different clocks. GobyMeds charges every 12 weeks and NextMeds charges every calendar month. That alone changes what a “month” costs, which is the whole reason this index recomputes every price.
- One price holds and the other climbs. GobyMeds’s price is a starting-dose price that climbs; NextMeds’s is the same at every dose. See what titration does to an advertised figure.
- What they advertise is not what they bill. GobyMeds advertises $133 and bills $145.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Neither is a seller’s own “/mo”. The full working for each — the charge, the period, the arithmetic and the date it was read — is on its own page: GobyMeds and NextMeds. The method is set out in how we verify.
To compare any two sellers in the index rather than these two, use the comparison tool.